K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
暂无分享,去创建一个
[1] G. Reboldi,et al. High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. , 2001, Archives of internal medicine.
[2] T. Greene,et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. , 2000, Kidney international.
[3] C. Mautalen,et al. Effect of parathyroid hormone on bone resorption in uremic patients. , 1976, Medicina.
[4] M. Praga,et al. [Effect of pravastatin on hypercholesterolemia associated with proteinuria]. , 1994, Anales de medicina interna.
[5] M. Christensen,et al. Parathyroid function after renal transplantation: interrelationships between renal function, serum calcium and serum parathyroid hormone in normocalcemic long-term survivors. , 1977, Clinical nephrology.
[6] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[7] R. Egdahl,et al. Experience with a radioimmunoassay of parathyroid hormone in human sera. , 1968, Transactions of the Association of American Physicians.
[8] P. Wilson,et al. Thrombogenic Risk Factors for Cardiovascular Disease in Dialysis Patients , 1999 .
[9] C. Pollock,et al. Protein intake in renal disease. , 1997, Journal of the American Society of Nephrology : JASN.
[10] P. Ballmer,et al. Influence of acidosis on protein metabolism. , 1995, Nutrition.
[11] Illiam,et al. THE EFFECT OF NISOLDIPINE AS COMPARED WITH ENALAPRIL ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES AND HYPERTENSION , 2000 .
[12] P. Aliabadi,et al. Intact parathyroid hormone levels in renal insufficiency , 1995, Calcified Tissue International.
[13] A. W. Gregory,et al. Differential diagnosis of acute renal failure. , 1980, Clinical nephrology.
[14] I. Cavill,et al. Iron status as measured by serum ferritin: the marker and its limitations. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] P. Watson,et al. Total body water volumes for adult males and females estimated from simple anthropometric measurements. , 1980, The American journal of clinical nutrition.
[16] T. Steinman,et al. Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. , 1989, Kidney international. Supplement.
[17] M. Drezner,et al. Altered divalent ion metabolism in early renal failure: role of 1,25(OH)2D. , 1985, Kidney international.
[18] P. Rossini,et al. New electrophysiological assessments for the early diagnosis of encephalopathy and peripheral neuropathy in chronic uraemia. , 1982, International journal of tissue reactions.
[19] P. Kimmel,et al. Quality of life and psychosocial relationships in patients with chronic renal insufficiency. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] K. Borch-Johnsen,et al. Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors , 1987, Diabetologia.
[21] R. Hays,et al. Assessing health and quality of life outcomes in dialysis: a report on an Institute of Medicine workshop. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] J. Adamson,et al. Erythropoiesis in patients with renal failure undergoing chronic dialysis. , 1967, The New England journal of medicine.
[23] H. Wedel,et al. Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[24] N. Clyne,et al. Quality of life in predialytic uremic patients , 1996, Quality of Life Research.
[25] J. Madans,et al. Proteinuria as a biomarker: risk of subsequent morbidity and mortality. , 1994, Environmental research.
[26] W. Mitch,et al. A SIMPLE METHOD OF ESTIMATING PROGRESSION OF CHRONIC RENAL FAILURE , 1976, The Lancet.
[27] D. Manninen,et al. Work disability, functional limitations, and the health status of kidney transplantation recipients posttransplant. , 1991, Clinical transplants.
[28] T. Jogestrand,et al. Effect of erythropoietin treatment on physical exercise capacity and on renal function in predialytic uremic patients. , 1992, Nephron.
[29] D. Di Landro,et al. Comparative outcome of patients on a conventional low protein diet versus a supplemented diet in chronic renal failure. , 1990, Contributions to nephrology.
[30] A. Besarab,et al. EFFECT OF CYCLOSPORINE AND DELAYED GRAFT FUNCTION ON POSTTRANSPLANTATION ERYTHROPOIESIS , 1985, Transplantation.
[31] A. Caggiula,et al. Registered dietitian time requirements in the Modification of Diet in Renal Disease Study. , 1995, Journal of the American Dietetic Association.
[32] L. Gallo. Cardiovascular Disease , 1995, GWUMC Department of Biochemistry Annual Spring Symposia.
[33] T. Ikizler,et al. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. , 1999, Kidney international.
[34] R. Berg,et al. Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[35] J. Bergström. Nutrition and mortality in hemodialysis. , 1995, Journal of the American Society of Nephrology : JASN.
[36] J. Eastwood,et al. Some biochemical, histological, radiological and clinical features of renal osteodystrophy. , 1973, Kidney international.
[37] V. Manninen,et al. Effects of hypertension and dyslipidemia on the decline in renal function. , 1995, Hypertension.
[38] G. Riccardi,et al. Metabolic consequences of feeding a high-carbohydrate, high-fiber diet to diabetic patients with chronic kidney failure. , 1988, The American journal of clinical nutrition.
[39] K. Forrest,et al. Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe. , 1998, International journal of epidemiology.
[40] K. Lynn,et al. Predicting renal survival in primary focal glomerulosclerosis from the time of presentation. , 1999, Kidney international.
[41] E. Bonucci,et al. Relationship between serum vitamin D metabolites and dietary intake of phosphate in patients with early renal failure. , 1987, Mineral and electrolyte metabolism.
[42] M. Coco,et al. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[43] J. Wikstrand,et al. Urinary albumin excretion--a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. , 1996, American journal of hypertension.
[44] R. Gottschalk,et al. Erythropoietin and iron. , 1999, Kidney international. Supplement.
[45] K. Borch-Johnsen,et al. Microalbuminuria: Implications for micro- and macrovascular disease , 1992, Diabetes Care.
[46] D. Petitti,et al. Membranous nephropathy: predictors of terminal renal failure. , 1984, Nephron.
[47] Efficacy and tolerability of recombinant human erythropoietin treatment in pre-dialysis patients: results of a multicenter study. , 1998, The International journal of artificial organs.
[48] S. Massry,et al. The physicochemical state and renal handling of divalent ions in chronic renal failure. , 1969, Archives of internal medicine.
[49] D. Sherrard,et al. Aluminum‐associated bone disease in chronic renal failure: High prevalence in a long‐term dialysis population , 1986, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[50] K. Atsumi,et al. Risk factors for vertebral fractures in renal osteodystrophy. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[51] J. Zazgornik,et al. High mortality and poor quality of life during predialysis period in type II diabetic patients with diabetic nephropathy. , 1994, Renal failure.
[52] G. Torrance,et al. Measurement of quality of life in end-stage renal disease: the time trade-off approach. , 1987, Clinical and investigative medicine. Medecine clinique et experimentale.
[53] R. Prince,et al. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure. , 1992, Nephron.
[54] D. Manninen,et al. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. , 1990, JAMA.
[55] E. Lewis,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.
[56] T A Louis,et al. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[57] G. Maschio,et al. Nutritional state in patients on long-term low-protein diet or with nephrotic syndrome. , 1989, Kidney international. Supplement.
[58] R. Degowin,et al. Effect of recombinant human erythropoietin on renal function in humans. , 1990, Kidney international.
[59] F. Valderrábano,et al. Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[60] J. Singer,et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[61] E. Bonucci,et al. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment. , 1989, Mineral and electrolyte metabolism.
[62] J. Yee,et al. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[63] D. Schwartz,et al. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. , 2001, Clinical nephrology.
[64] G. Viberti,et al. Glomerular Hyperfiltration in the Prediction of Nephropathy in IDDM: A 10-Year Follow-Up Study , 1996, Diabetes.
[65] D. Levy,et al. Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study. , 2000, The American journal of medicine.
[66] G. Viberti,et al. Diabetic Nephropathy: Future avenue , 1992, Diabetes Care.
[67] E. Lowrie,et al. The relative contribution of measured variables to death risk among hemodialysis patients , 1994 .
[68] D E Manyari,et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.
[69] J. Brod,et al. Effect of correction of anemia on the glomerular filtration rate in chronic renal failure. , 1967, Israel journal of medical sciences.
[70] Z. Massy,et al. Dyslipidaemia and the progression of renal disease in chronic renal failure patients. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[71] E. Araki,et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.
[72] W. Mitch,et al. Should protein intake be restricted in predialysis patients? , 1999, Kidney international.
[73] P. Jungers,et al. Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[74] R A Kronmal,et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. , 1998, JAMA.
[75] S. Kenny,et al. Proteinuria and Mortality in Diabetes: the WHO Multinational Study of Vascular Disease in Diabetes , 1995, Diabetic medicine : a journal of the British Diabetic Association.
[76] A. Kanagasabapathy,et al. Prevalence of diabetic nephropathy in non-insulin dependent diabetics. , 1991, The Indian journal of medical research.
[77] M. Elisaf,et al. Increased Serum Lipoprotein(a) Levels in Patients with Early Renal Failure , 1999, Annals of Internal Medicine.
[78] R. Tamarozzi,et al. Early skeletal changes of the hand phalanges in patients with chronic renal failure. , 1985, The International journal of artificial organs.
[79] H. Parving,et al. Surrogate endpoints and renal protection: focus on microalbuminuria. , 1997, Blood pressure. Supplement.
[80] S. Madsen,et al. Degree and course of skeletal demineralization in patients with chronic renal insufficiency. , 1978, Scandinavian journal of urology and nephrology.
[81] C. Jackson,et al. MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS Islington Diabetes Survey , 1988, The Lancet.
[82] V. Young,et al. Long-term adaptive responses to dietary protein restriction in chronic renal failure. , 1995, The American journal of physiology.
[83] A. Collins,et al. Trends in anemia treatment with erythropoietin usage and patient outcomes. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[84] R. Saracho,et al. The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[85] L. Snetselaar,et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. , 1995, Journal of the American Dietetic Association.
[86] S. Wannamethee,et al. Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. , 1997, Stroke.
[87] R. Foley,et al. Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[88] R. Whitehouse,et al. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. , 1993, Kidney international.
[89] Gordon H. Guyatt,et al. Users' Guides to the Medical Literature: V. How to Use an Article About Prognosis , 1994 .
[90] A. Robson,et al. Control of phosphate excretion in uremic man. , 1968, The Journal of clinical investigation.
[91] N. Kutner,et al. REHABILITATION, AGING AND CHRONIC RENAL DISEASE , 1992, American journal of physical medicine & rehabilitation.
[92] M. Suzuki,et al. Renal osteodystrophy in early chronic renal failure. , 1980, Contributions to nephrology.
[93] F. Locatelli,et al. Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency , 1991, The Lancet.
[94] O. Tomonaga,et al. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients , 1997, Diabetologia.
[95] M. Laakso,et al. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. , 1996, Stroke.
[96] B. Bistrian. Role of the systemic inflammatory response syndrome in the development of protein-calorie malnutrition in ESRD. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[97] G. Beck,et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. , 1998, Clinical nephrology.
[98] A. Allegra,et al. Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy , 2000, Clinical pharmacology and therapeutics.
[99] E. Ritz,et al. Bone histology in incipient and advanced renal failure. , 1976, Kidney international.
[100] M. Ravid,et al. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. , 1998, Archives of internal medicine.
[101] J. Coresh,et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. , 2000, Kidney international.
[102] F. Llach,et al. Hyperphosphatemia in end-stage renal disease patients: pathophysiological consequences. , 1999, Kidney international. Supplement.
[103] C. Lasseur,et al. Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated by a supplemented very low protein diet. , 2000, Journal of the American Society of Nephrology : JASN.
[104] S. Zeger,et al. The effect of a keto acid-amino acid supplement to a restricted diet on the progression of chronic renal failure. , 1984, The New England journal of medicine.
[105] A. Krolewski,et al. Hypercholesterolemia--a determinant of renal function loss and deaths in IDDM patients with nephropathy. , 1994, Kidney international. Supplement.
[106] C. Hsu,et al. Are we mismanaging calcium and phosphate metabolism in renal failure? , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[107] Mei Wang,et al. Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[108] H. Bucht,et al. Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearance. , 1991, Kidney international.
[109] J. Walls,et al. The metabolic consequences of the correction of acidosis in uraemia. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[110] M. Haneda,et al. Progression of diabetic nephropathy. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[111] A. Michael,et al. A solid phase fluorescent immunoassay for the measurement of human urinary albumin. , 1984, Kidney international.
[112] K. Borch-Johnsen,et al. Microalbuminuria: an important diagnostic tool. , 1994, Journal of diabetes and its complications.
[113] E. Ritz,et al. Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[114] A. Cupisti,et al. Nutritional treatment of renal failure in type 1 diabetic nephropathy. , 1988, Clinical nephrology.
[115] W. O'Fallon,et al. Primary Hyperparathyroidism and the Risk of Fracture: A Population‐Based Study , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[116] A. Levin,et al. Cardiovascular disease in chronic renal insufficiency. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[117] R M Hakim,et al. Initiation of dialysis. , 1994, Advances in nephrology from the Necker Hospital.
[118] B. Myers,et al. Slope of serial glomerular filtration rate and the progression of diabetic glomerular disease. , 1993, Journal of the American Society of Nephrology : JASN.
[119] G. Sundkvist,et al. Relationships among glomerular filtration rate, albuminuria, and autonomic nerve function in insulin-dependent and non-insulin-dependent diabetes mellitus. , 1997, Journal of diabetes and its complications.
[120] S. Madsen,et al. Renal handling of phosphate in relation to serum parathyroid hormone levels. , 2009, Acta medica Scandinavica.
[121] M. Goel,et al. Observations on peripheral neuropathy in chronic uraemics. , 1978, Journal of Association of Physicians of India.
[122] C. Tetta,et al. C REACTIVE PROTEIN IN PATIENTS WITH CHRONIC RENAL DISEASES , 2001, Renal failure.
[123] M. Walser,et al. Can renal replacement be deferred by a supplemented very low protein diet? , 1999, Journal of the American Society of Nephrology : JASN.
[124] J. Kanis,et al. Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure , 1995, BMJ.
[125] A. Dusso,et al. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. , 1996, The Journal of clinical investigation.
[126] K. Forrest,et al. The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[127] N. Kutner. Assessing end-stage renal disease patients' functioning and well-being: measurement approaches and implications for clinical practice. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[128] H. Malluche,et al. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[129] A. Barrientos,et al. Cardiovascular effects of recombinant human erythropoietin in predialysis patients. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[130] W. G. Walker. Hypertension-related renal injury: a major contributor to end-stage renal disease. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[131] S. Nielsen,et al. Microalbuminuria in non-insulin-dependent diabetes. , 1992, Clinical nephrology.
[132] E. Bonucci,et al. Metabolic acidosis and osteodystrophic bone disease in predialysis chronic renal failure: effect of calcitriol treatment. , 1995, Mineral and electrolyte metabolism.
[133] S. Downie,et al. Correction of acidosis in hemodialysis decreases whole-body protein degradation. , 1997, Journal of the American Society of Nephrology : JASN.
[134] A. Caggiula,et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. , 1995, Journal of the American Dietetic Association.
[135] G. de Klerk,et al. Serum erythropoietin (ESF) titers in anemia of chronic renal failure. , 1982, The Journal of laboratory and clinical medicine.
[136] A R Nissenson,et al. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. , 1996, Journal of the American Society of Nephrology : JASN.
[137] G. Mintz,et al. Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietin. , 1991, Transplantation proceedings.
[138] K. Johansen,et al. Physical functioning and exercise capacity in patients on dialysis. , 1999, Advances in renal replacement therapy.
[139] P. Eskildsen,et al. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. , 1999, Kidney international.
[140] G. Beck,et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. , 1997, Kidney international.
[141] A. Donker,et al. Clinical usefulness of measurement of urinary albumin excretion in diabetes mellitus. , 1993, The Netherlands journal of medicine.
[142] F. Dekker,et al. Quality of Life in Predialysis End-Stage Renal Disease Patients at the Initiation of Dialysis Therapy , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[143] J. Fisher. Mechanism of the anemia of chronic renal failure. , 1980, Nephron.
[144] H. Gerstein,et al. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. , 1997, Archives of internal medicine.
[145] A. Levin,et al. Defining a renal anemia management period. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[146] J. Delmez,et al. Pathogenesis of secondary hyperparathyroidism. , 1999, Kidney international. Supplement.
[147] O. Knoll,et al. Detection of uremic neuropathy by reflex response latency , 1980, Journal of the Neurological Sciences.
[148] P. Rampal,et al. Quality of life in long-term home enteral nutrition patients. , 2000, Clinical nutrition.
[149] S. J. Poirier. Preserving the diabetic kidney. , 1998, The Journal of family practice.
[150] B. V. Shah,et al. Spontaneous changes in the rate of decline in reciprocal serum creatinine: errors in predicting the progression of renal disease from extrapolation of the slope. , 1992, Journal of the American Society of Nephrology : JASN.
[151] W. Mitch,et al. Nutritional Considerations in the Treatment of Patients with Chronic Uremia , 1998, Mineral and Electrolyte Metabolism.
[152] R. Prince,et al. A Case–Control Study of Quality of Life and Functional Impairment in Women with Long–Standing Vertebral Osteoporotic Fracture , 1999, Osteoporosis International.
[153] Y. Boirie,et al. Alterations of protein metabolism by metabolic acidosis in children with chronic renal failure. , 2000, Kidney international.
[154] A. Kliger,et al. Clinical practice guidelines in end-stage renal disease: a strategy for implementation. , 1999, Journal of the American Society of Nephrology : JASN.
[155] K. Maurer,et al. Sample design: Third National Health and Nutrition Examination Survey. , 1992, Vital and health statistics. Series 2, Data evaluation and methods research.
[156] M. Olson,et al. Dietary satisfaction correlated with adherence in the Modification of Diet in Renal Disease Study. , 1995, Journal of the American Dietetic Association.
[157] G. Remuzzi,et al. Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen) , 2000, Journal of the American Society of Nephrology : JASN.
[158] B. Panayiotou,et al. Microalbuminuria: Pathogenesis, Prognosis and Management , 1994, The Journal of international medical research.
[159] M. Christensen,et al. Bone composition and parathyroid function in chronic renal failure. , 2009, Acta medica Scandinavica.
[160] C. Thompson,et al. Microalbuminuria: A Marker to Increased Renal and Cardiovascular Risk in Diabetes Mellitus , 1997, Scottish medical journal.
[161] J. Goodwin,et al. The association between chronic diseases and depressive symptomatology in older Mexican Americans. , 1998, The journals of gerontology. Series A, Biological sciences and medical sciences.
[162] M. Marre,et al. Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension. , 1997, Clinical nephrology.
[163] T. Lehtimäki,et al. Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Diabetic Albuminuria in Patients with NIDDM Followed Up for 9 Years , 1998, Nephron.
[164] S. Massry,et al. Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects. , 1973, Annals of internal medicine.
[165] B. Brenner,et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.
[166] J. Dillon. The quantitative relationship between treated blood pressure and progression of diabetic renal disease. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[167] A. S. Appel,et al. Acute Renal Failure , 1960, Advances in Experimental Medicine and Biology.
[168] H. Parving. Diabetic hypertensive patients. Is this a group in need of particular care and attention? , 1999, Diabetes care.
[169] M. Blaufox,et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. , 1989, Hypertension.
[170] Y. Pei,et al. Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. , 1992, Kidney international.
[171] P. J. Friedman. Serum creatinine: an independent predictor of survival after stroke , 1991, Journal of internal medicine.
[172] J. Achard,et al. Risk factors of renal failure progression two years prior to dialysis. , 1999, Clinical nephrology.
[173] B. Lindholm,et al. Malnutrition, cardiac disease, and mortality: an integrated point of view. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[174] Ki-Up Lee,et al. Prevalence and Associated Features of Albuminuria in Koreans with NIDDM , 1995, Diabetes Care.
[175] E. Zeitler,et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[176] W. Mitch,et al. Factors causing malnutrition in patients with chronic uremia. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[177] M. Buset,et al. Radioimmunoassay of erythropoietin in chronic uraemia or anephric patients. , 2009, Scandinavian journal of haematology.
[178] M. Rudnick,et al. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[179] G. Beck,et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. , 1995, Journal of the American Society of Nephrology : JASN.
[180] L. Oldrizzi,et al. Nutritional assessment in patients with early renal insufficiency on long-term low protein diet. , 1986, Contributions to nephrology.
[181] L. Magder,et al. A crossover comparison of progression of chronic renal failure: ketoacids versus amino acids. , 1993, Kidney international.
[182] S. Nielsen,et al. The clinical course of renal function in NIDDM patients with normo‐ and microalbuminuria , 1997, Journal of internal medicine.
[183] B. Tönshoff,et al. Derangements of the somatotropic hormone axis in chronic renal failure. , 1997, Kidney international. Supplement.
[184] G. Jerums,et al. Microalbuminuria: Prognostic and Therapeutic Implications in Diabetes Mellitus , 1994, Diabetic medicine : a journal of the British Diabetic Association.
[185] J. Walls,et al. Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronic uremia. , 1991, Kidney international.
[186] P. Jungers,et al. Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[187] C. Mogensen,et al. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas , 1999, Diabetologia.
[188] F. Bartter,et al. Hyperparathyroidism and renal failure. , 1955, Bulletin. Tufts-New England Medical Center.
[189] A. Greenberg,et al. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. , 1988, The Journal of clinical endocrinology and metabolism.
[190] F. Port,et al. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[191] D. Bushinsky. The contribution of acidosis to renal osteodystrophy. , 1995, Kidney international.
[192] P. Stenvinkel,et al. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure. , 1998, Kidney international.
[193] C. Moore,et al. Characterization of the anemia associated with chronic renal insufficiency. , 1958, The American journal of medicine.
[194] David C. Murray,et al. Outcome and risk factors for left ventricular disorders in chronic uraemia. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[195] Joni K. Evans,et al. Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. , 1996, Kidney international.
[196] Giuseppe Mancia,et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) , 2000, The Lancet.
[197] V. Rigalleau,et al. Outcome of nutritional status and body composition of uremic patients on a very low protein diet. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[198] G. D'Amico,et al. Dietary control may influence several risk factors in patients with chronic renal failure. , 1990, Contributions to nephrology.
[199] R. Gleason,et al. Autonomic function in type I diabetes mellitus complicated by nephropathy. A cross-sectional analysis in the presymptomatic phase. , 1995, American journal of hypertension.
[200] M. Hori,et al. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[201] W. Keane. Proteinuria: its clinical importance and role in progressive renal disease. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[202] R. McGonigle,et al. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. , 1984, Kidney international.
[203] E. Ritz,et al. Nephropathy in patients with type 2 diabetes mellitus. , 1999, The New England journal of medicine.
[204] J. Rastad,et al. Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department , 1997, European journal of clinical investigation.
[205] N. Powe,et al. Formal literature review of quality-of-life instruments used in end-stage renal disease. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[206] J. Delmez,et al. Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[207] G. Bakris,et al. Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans. , 1997, Hypertension.
[208] M. A. Ferreira,et al. Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[209] J. Stoves,et al. A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[210] P. Raskin,et al. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. , 1991, The New England journal of medicine.
[211] W. Oertel,et al. Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome , 1998, Movement disorders : official journal of the Movement Disorder Society.
[212] G. Viberti,et al. Microalbuminuria Predicts Mortality in Noninsulin‐dependent Diabetes , 1984, Diabetic medicine : a journal of the British Diabetic Association.
[213] K. Koch,et al. Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. , 1979, Blood.
[214] C. Winearls. Recombinant human erythropoietin: 10 years of clinical experience. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[215] K. Lau,et al. Phosphate excess and progressive renal failure: the precipitation-calcification hypothesis. , 1989, Kidney international.
[216] D. Silverberg,et al. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[217] J. Zazgornik,et al. Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[218] G. Beck,et al. Cardiovascular disease risk factors in chronic renal insufficiency. , 2002, Clinical nephrology.
[219] P. Stenvinkel,et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. , 1999, Kidney international.
[220] D. Burn,et al. Neurology and the kidney , 1998, Journal of neurology, neurosurgery, and psychiatry.
[221] Y. Kawaguchi,et al. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. , 1997, Nephron.
[222] P. Deoreo,et al. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[223] V. Campese,et al. Mechanisms of autonomic nervous system dysfunction in uremia. , 1981, Kidney international.
[224] E. Friedman,et al. Dismal rehabilitation in geriatric inner-city hemodialysis patients. , 1994, JAMA.
[225] S. Yusuf,et al. Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial , 2001, Annals of Internal Medicine.
[226] R. Tisch,et al. Insulin-Dependent Diabetes Mellitus , 1996, Cell.
[227] C. E. Mogensen,et al. Proliferative diabetic retinopathy: at risk patients identified by early detection of microalbuminuria , 1985, Acta ophthalmologica.
[228] H. Wedel,et al. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[229] D. Sherrard,et al. Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[230] P. Jungers,et al. Factors affecting progression in advanced chronic renal failure. , 1993, Clinical nephrology.
[231] Z. Varghese,et al. Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. , 1993, Kidney international.
[232] A. Zanchetti,et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. , 2001, Journal of the American Society of Nephrology : JASN.
[233] A. Cupisti,et al. Nutritional state of severe chronic renal failure patients on a low-protein supplemented diet. , 1990, Contributions to nephrology.
[234] P. Fröhling,et al. Evaluation of nutritional status in the GDR trial. , 1990, Contributions to nephrology.
[235] W. Tierney,et al. Clinical correlates of functional status in patients with chronic renal insufficiency. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[236] J. Adamson,et al. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. , 1989, Annals of internal medicine.
[237] A. Donker,et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. , 1989, Kidney international. Supplement.
[238] M. Miller,et al. Serum immunoreactive erythropoietin levels in patients with polycystic kidney disease as compared with other hemodialysis patients. , 1985, Nephron.
[239] F. V. Lente,et al. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[240] D. Sherrard. Control of Renal Bone Disease , 1994 .
[241] L. Chambless,et al. A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study. , 1999, Archives of internal medicine.
[242] G. Guyatt,et al. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. , 1994, JAMA.
[243] L. Niskanen,et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial , 1999, The Lancet.
[244] R. McGonigle,et al. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure. , 1984, The Journal of laboratory and clinical medicine.
[245] H. Klehr,et al. Immunoreactive parathyroid hormone in early and advanced renal failure. , 1982, Nephron.
[246] K. Latta,et al. Chronic Renal Failure: An Overview from a Pediatric Perspective , 1998, Nephron.
[247] E. Boyko,et al. Responsiveness of the SF-36 among veterans with diabetes mellitus. , 2000, Journal of diabetes and its complications.
[248] A. Manatunga,et al. Mechanisms permitting nephrotic patients to achieve nitrogen equilibrium with a protein-restricted diet. , 1997, The Journal of clinical investigation.
[249] A. Cheung,et al. Determinants of serum 1,25(OH)2D levels in renal disease. , 1983, Kidney international.
[250] G. Hughes,et al. THE SYSTOLIC HYPERTENSION IN THE ELDERLY PROGRAM , 1982 .
[251] A. Alzaid. Microalbuminuria in Patients With NIDDM: An Overview , 1996, Diabetes Care.
[252] S. Massry,et al. On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency. , 1985, The Journal of clinical endocrinology and metabolism.
[253] O. Pedersen,et al. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study , 1999, The Lancet.
[254] S. Greenfield,et al. The Medical Outcomes Study. An application of methods for monitoring the results of medical care. , 1989, JAMA.
[255] G. Woodrow,et al. Measurement of body composition in chronic renal failure: comparison of skinfold anthropometry and bioelectrical impedance with dual energy X-ray absorptiometry. , 1996, European journal of clinical nutrition.
[256] G. Remuzzi,et al. Abnormal permeability to proteins and glomerular lesions: a meta-analysis of experimental and human studies. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[257] B. Fagerberg,et al. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. , 1997, The American journal of cardiology.
[258] P. Whelton,et al. Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[259] H. Saha. Calcium and vitamin D homeostasis in patients with heavy proteinuria. , 1994, Clinical nephrology.
[260] M. Gall. Albuminuria in non-insulin-dependent diabetes mellitus. Prevalence, causes, and consequences. , 1997, Danish medical bulletin.
[261] V. Nielsen. The peripheral nerve function in chronic renal failure. VI. The relationship betweeen sensory and motor nerve conduction and kidney function, azotemia, age, sex, and clinical neuropathy. , 1973, Acta medica Scandinavica.
[262] F. Port,et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[263] E. Slatopolsky,et al. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. , 1973, Kidney international.
[264] A. Kliger. Clinical practice guidelines and performance measures in ESRD. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[265] Jasper Lin,et al. Effect of long-term low-dose aluminum-containing agents on hemoglobin synthesis in patients with chronic renal insufficiency. , 1996, Nephron.
[266] S. Leurgans,et al. Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy. , 1996, Kidney international.
[267] K. Baboolal,et al. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[268] P. Vestergaard,et al. Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism , 2000, BMJ : British Medical Journal.
[269] A. Kausz,et al. Anemia management in patients with chronic renal insufficiency. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[270] T. Kigoshi,et al. Reversed circadian blood pressure rhythm independently predicts endstage renal failure in non-insulin-dependent diabetes mellitus subjects. , 1999, Journal of diabetes and its complications.
[271] M. Emoto,et al. Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure. , 1998, Journal of nephrology.
[272] M. Rocco,et al. Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[273] M. Budisavljevic,et al. Calciphylaxis in chronic renal failure. , 1996, Journal of the American Society of Nephrology : JASN.
[274] E. Bonucci,et al. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[275] M. Walser,et al. Progression of chronic renal failure in man. , 1990, Kidney international.
[276] P. Kimmel,et al. Perception of illness and depression in chronic renal disease. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[277] F. Takaku,et al. Serum erythropoietin titers in the anemia of chronic renal failure and other hematological states. , 1987, International journal of cell cloning.
[278] A. Levey,et al. "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. , 1998, Kidney international.
[279] P. Andersen,et al. The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus , 1985, Diabetologia.
[280] Tom Greene,et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[281] M. Fujisawa,et al. Assessment of health-related quality of life in renal transplant and hemodialysis patients using the SF-36 health survey. , 2000, Urology.
[282] V. Cambi,et al. The influence of glomerular filtration rate on uremic polyneuropathy. , 1980, Clinical nephrology.
[283] G. D'Amico,et al. Uremic polyneuropathy: a clinical and electrophysiological study in 135 short- and long-term hemodialyzed patients. , 1991, Clinical nephrology.
[284] Z. Massy,et al. Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[285] A. Besarab,et al. Erythropoietin response to blood loss in hemodialysis patients in blunted but preserved. , 1994, ASAIO journal.
[286] H. Parving,et al. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study , 1997, BMJ.
[287] C. Mogensen,et al. Microalbuminuria as predictor of increased mortality in elderly people. , 1990, BMJ.
[288] T. Sugimoto,et al. Effect of dietary protein restriction on proteinuria in non-insulin-dependent diabetic patients with nephropathy. , 1991, Journal of nutritional science and vitaminology.
[289] Y. Takamitsu,et al. Effect of low protein diet and surplus of essential amino acids on the serum concentration and the urinary excretion of methylguanidine and guanidinosuccinic acid in chronic renal failure. , 1979, Nephron.
[290] Y. Pei,et al. The spectrum of bone disease in end-stage renal failure--an evolving disorder. , 1993, Kidney international.
[291] G. Savazzi. Nerve conduction times in uremia. , 1981, The International journal of artificial organs.
[292] S. Donnelly,et al. Erythropoietin deficiency in hyporeninemia. , 1999, American Journal of Kidney Diseases.
[293] L. Dworkin,et al. Antihypertensive drugs, dietary salt, and renal protection: how low should you go and with which therapy? , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[294] R. Parker,et al. Spontaneous dietary protein intake during progression of chronic renal failure. , 1995, Journal of the American Society of Nephrology : JASN.
[295] T. Akiba,et al. Levels of serum 1,25(OH)2D in patients with pre-dialysis chronic renal failure. , 1996, The Tohoku journal of experimental medicine.
[296] T. Ikizler,et al. Nutrition in end-stage renal disease. , 1996, Kidney international.
[297] Z. Taralov,et al. Erythrocyte ferritin levels in chronic renal failure patients. , 1998, Folia medica.
[298] D. Isacson,et al. Hypertension and health-related quality of life. an epidemiological study in Sweden. , 2001, Journal of clinical epidemiology.
[299] J. Kopple,et al. Energy expenditure in patients with chronic renal failure. , 1986, Kidney international.
[300] L. Lins,et al. Progressive decline in renal function induces a gradual decrease in total hemoglobin and exercise capacity. , 1994, Nephron.
[301] G. Beck,et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. , 1994, The New England journal of medicine.
[302] D Hernández,et al. Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. , 1995, Kidney international.
[303] C. Mogensen,et al. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. , 1984, The New England journal of medicine.
[304] M. Emoto,et al. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. , 1999, Kidney international.
[305] P. R. de Cotret. Relationships among diabetes, microalbuminuria, and ACE inhibition. , 1998, Journal of cardiovascular pharmacology.
[306] C. Catena,et al. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure. , 1999, Kidney international.
[307] P. Messa,et al. The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[308] A. Besarab,et al. Dynamics of erythropoiesis following renal transplantation. , 1987, Kidney international.